UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Drugmakers boost production capacity amid Covid-19
Local pharmaceutical companies are expanding their manufacturing facilities...
by Kim Chan-hyuk
|
2020-08-28 14:57
라인
Genexine's cytokine drug effective on severe Covid-19 patients
Genexine said Thursday that it has confirmed the safety and efficacy of lon...
by Shim Hyun-tai
|
2020-08-27 18:05
라인
Drugmakers to sue government for limiting choline alfoscerate benefit
Manufacturers of choline alfoscerate, a dementia drug, are reportedly prepa...
by Kim Yun-mi
|
2020-08-27 14:26
라인
Stocks of 3 Covid-19 vaccine developers spike
Three Korean drugmakers working on a Covid-19 vaccine have garnered robust ...
by Kim Chan-hyuk
|
2020-08-27 14:07
라인
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai
|
2020-08-26 17:47
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai
|
2020-08-26 16:19
라인
Novartis fails trial on skin cancer drug candidate spartalizumab
Novartis said it its phase-3 trial on immunotherapy spartalizumab, a progra...
by Kim Yun-mi
|
2020-08-26 11:11
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai
|
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai
|
2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai
|
2020-08-25 14:50
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai
|
2020-08-24 18:02
라인
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai
|
2020-08-24 18:01
라인
GC Pharma collects more plasma to speed up work on Covid-19 treatment
GC Pharma said it would collect more plasma from recovered Covid-19 patient...
by Kim Chan-hyuk
|
2020-08-24 17:15
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
An increasing number of pharmaceutical companies are holding the activities...
by Kim Yun-mi
|
2020-08-21 16:00
라인
Hanmi terminates global P2 trial for poziotinib
Hanmi Pharmaceutical has terminated its global phase 2 clinical trial for p...
by Lee Han-soo
|
2020-08-21 15:56
라인
Daewoong to co-develop esophagitis drug for treating Covid-19
Daewoong Pharmaceutical signed an agreement with Institut Pasteur Korea (IP...
by Shim Hyun-tai
|
2020-08-20 18:41
라인
Yuhan licenses out gastrointestinal treatment to US partner
Yuhan Corp. said that it has licensed out YH12852, a gastrointestinal motil...
by Lee Han-soo
|
2020-08-20 16:58
라인
Regulator OKs P2 trial of Covid-19 plasma therapy
GC said that the Ministry of Food and Drug Safety has approved the phase 2 ...
by Lee Han-soo
|
2020-08-20 14:55
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top